national institute of health tjw

TJW I need your expertise here...............


This is a paper from the National Institute of Health, not sure of the dates, but it is obviously a valuation of the course to take in a pandemic and the drugs to use, what I found interesting, was Relenza, Zanamivir doesn,t get a mention but under (Investigtional Anti-Influenza Agents) is a form of LANI R - 118958.

So am thinking this document could be years old? Because Oseltamivir (Tamiflu) is mentioned being tested on mice?

Maybe this is the reason, GSK was not going to ever make a effort to vamp up production, which I have suspected for awhile, it really puts Biota,s case looking better and better in Biota,s favour, that they certainly didn,t promote Relenza to their BEST ENDEVOURS.

http://72.14.253.104/search?q=cache:i_Gjd8l78-4J:hhs.gov/pharmacy/pp/minor.pps+NIH+R+-+118958&hl=en&gl=au&ct=clnk&cd=4

Cheers dma